metadata:
  version: "1.0.0"
  description: "mRNA clinical trial verification and classification in single step"
  
system_prompt: |
  You are an expert in clinical trial analysis specializing in mRNA-based therapeutics. Your task is to analyze 
  text describing clinical trials and perform two key functions:

  1. VERIFICATION: Determine if this is an mRNA-based interventional trial
  2. CLASSIFICATION: If eligible, categorize into exactly one of six therapeutic categories

  You must be precise and provide clear reasoning based on the trial data.

user_template: |
  Please analyze the following clinical trial:

  NCT ID: {{ nct_id }}
  Brief Title: {{ brief_title }}
  Official Title: {{ official_title }}
  Brief Summary: {{ brief_summary }}
  Detailed Description: {{ detailed_description|default("No detailed description available") }}
  Conditions: {{ conditions|join(', ') if conditions else "Not specified" }}

  Interventions:
  {% if interventions %}
  {% for intervention in interventions %}
  - Type: {{ intervention.type|default("Unknown type") }}
    Name: {{ intervention.name|default("Unknown name") }}
    Description: {{ intervention.description|default("No description") }}
  {% endfor %}
  {% else %}
  - No intervention details available
  {% endif %}

  Phase: {{ phases|join(', ') if phases else "Unknown phase" }}
  Sponsor: {{ sponsor|default("Unknown sponsor") }}

  KNOWN mRNA INDICATORS TO LOOK FOR:
  
  Key mRNA Companies: 
  {% if mrna_companies and mrna_companies.companies %}
  {% for company in mrna_companies.companies[:8] %}
  - {{ company.name }}{% if company.aliases %} ({{ company.aliases[:2]|join(', ') }}){% endif %}
  {% endfor %}
  {% else %}
  - Moderna, BioNTech, CureVac, Intellia Therapeutics, Beam Therapeutics, Translate Bio
  {% endif %}

  mRNA Technology Clues:
  - Explicit mentions: mRNA, messenger RNA, nucleoside-modified mRNA
  - Drug codes: mRNA-XXXX, NTLA-XXXX, BNT162b2, mRNA-1273
  - Delivery: Lipid nanoparticles (LNP) + genetic therapy
  - Approaches: Gene editing, base editing, mRNA vaccines

  VERIFICATION STEP:
  First, determine if the clinical trial meets BOTH of these criteria:
  - It is an interventional trial (not observational)
  - It involves an mRNA-based medicine or therapeutic (including mRNA vaccines)
  
  If the trial does NOT meet both criteria, clearly state that it is not an eligible mRNA interventional trial and explain why.

  CLASSIFICATION STEP:
  If the trial IS eligible (meets both criteria above), classify it into EXACTLY ONE of these six categories:

  [1] Cancer (including immunotherapies, immunomodulation, cancer antibodies; excluding CAR-T & cell therapy)
  Definition: Encodes tumor antigens, cytokines, or immunomodulators to activate or augment the immune system for cancer therapy.

  Look for: Tumor antigens, cancer vaccines, immunotherapy approaches that are not cell-based
  Key indicators: Mentions of solid tumors, melanoma, carcinoma, tumor-associated antigens, cancer immunotherapy
  Exclusion: CAR-T approaches, ex vivo cell engineering

  [2] Protein Replacement
  Definition: Delivers mRNA encoding a missing or defective protein, often for monogenic, inherited conditions.

  Look for: Rare diseases, inherited disorders, protein deficiencies
  Key indicators: References to enzyme replacement, protein restoration, monogenic disorders
  Examples: Cystic fibrosis, hemophilia, metabolic disorders, lysosomal storage diseases

  [3] Genetic Medicines (gene editors, base editors, epigenome editors, etc.)
  Definition: Encodes tools (e.g., CRISPR, base editors) to correct, silence, or modify disease-causing genes permanently.

  Look for: Gene editing, CRISPR, Cas9, base editing, epigenome modification
  Key indicators: Permanent genetic modification, gene correction, gene silencing
  Distinguished by: Focus on modifying the genome itself, not just temporary protein expression

  [4] mRNA-Encoded Biologics
  Definition: Delivers mRNA encoding functional biologics (e.g., antibodies, enzymes, hormones, cytokines) for transient but potent therapeutic effect.

  Look for: Antibody expression, enzyme delivery, hormone replacement that is NOT addressing an inherited disorder
  Key indicators: Temporary expression of therapeutic proteins, biologic drugs
  Examples: mRNA encoding therapeutic antibodies, growth factors, anti-inflammatory cytokines

  [5] Cell Therapies (including CAR-T)
  Definition: Uses mRNA to engineer immune cells ex vivo (or potentially in vivo) to recognize disease targets.

  Look for: CAR-T, T cell engineering, ex vivo modification, adoptive cell transfer
  Key indicators: T cells, NK cells, chimeric antigen receptors, cell engineering
  Distinguished by: Focus on modifying cells, typically immune cells, rather than direct mRNA delivery to patients

  [6] Infectious Disease Vaccines
  Definition: Encodes viral or bacterial antigens for immune system training and prevention. Includes all trials evaluating mRNA vaccines whether for initial vaccination or booster doses.

  Look for: Vaccines, infectious agents, pathogens, prophylaxis, immunogenicity studies
  Key indicators: Virus names (e.g., SARS-CoV-2, influenza), bacterial pathogens, preventive approach, immunization, safety and immunogenicity evaluations
  Examples: COVID-19 vaccines (primary series or boosters), influenza, RSV, HIV vaccine candidates

  RESPONSE FORMAT:
  VERIFICATION: [State whether this is an eligible mRNA interventional trial and why/why not]

  CLASSIFICATION: [If eligible, specify ONE category number and name]

  CONFIDENCE LEVEL: [HIGH/MEDIUM/LOW]

  RATIONALE: [Provide a detailed explanation for your classification, citing specific evidence from the trial information]

  KEY INDICATORS: [List 3-5 specific phrases or concepts from the trial description that support your classification]

template_variables:
  - nct_id
  - brief_title
  - official_title
  - brief_summary
  - detailed_description
  - conditions
  - interventions
  - phases
  - sponsor
  - mrna_companies